Sun Jianbo, Rothschild Gerson, Pefanis Evangelos, Basu Uttiya
Department of Microbiology and Immunology; College of Physicians and Surgeons; Columbia University; New York, NY USA.
Transcription. 2013 May-Jun;4(3):127-35. doi: 10.4161/trns.24556. Epub 2013 Apr 12.
B cells utilize three DNA alteration strategies-V(D)J recombination, somatic hypermutation (SHM) and class switch recombination (CSR)-to somatically mutate their genome, thereby expressing a plethora of antibodies tailor-made against the innumerable antigens they encounter while in circulation. Of these three events, the single-strand DNA cytidine deaminase, Activation Induced cytidine Deaminase (AID), is responsible for SHM and CSR. Recent advances, discussed in this review article, point toward various components of RNA polymerase II "stalling" machinery as regulators of AID activity during antibody diversification and maintenance of B cell genome integrity.
B细胞利用三种DNA改变策略——V(D)J重组、体细胞超突变(SHM)和类别转换重组(CSR)——对其基因组进行体细胞突变,从而表达出大量针对其在循环中遇到的无数抗原量身定制的抗体。在这三种事件中,单链DNA胞苷脱氨酶,即激活诱导胞苷脱氨酶(AID),负责SHM和CSR。本文综述中讨论的最新进展表明,RNA聚合酶II“停滞”机制的各种成分是抗体多样化和B细胞基因组完整性维持过程中AID活性的调节因子。